<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45371">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02098226</url>
  </required_header>
  <id_info>
    <org_study_id>BDAL-2013-001</org_study_id>
    <nct_id>NCT02098226</nct_id>
  </id_info>
  <brief_title>Evaluation of MALDI Biotyper CA System for Detection of Gram- and Gram+ Bacteria and Yeasts</brief_title>
  <official_title>Method Comparison Protocol: MALDI Biotyper-Clinical Applications (MBT-CA) Phase 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bruker Daltonics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bruker Daltonics</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to confirm that the MBT-CA System identifies medically significant
      bacteria and yeasts from an isolated colony from any sample type processed by the clinical
      laboratory. For this purpose MBT-CA test results will be compared to bi-directional
      sequencing results.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bacteria or yeast isolates (1) fresh from primary culture plates, (2) collected directly
      from clinical samples, stored in the refrigerator or frozen or (3) well characterized
      organisms from a variety of contemporary culture collections will be included in the study.
      All organisms to be included in the study will be cultured on an agar medium prior to
      measurement.

      Testing will be performed for various Gram negative and Gram positive bacteria and yeasts as
      outlined below. Several thousands of samples will be measured via MBT-CA systems based on
      MALDI-TOF MS technology (matrix assisted laser desorption ionisation time-of-flight mass
      spectrometry) at the test sites as fresh or frozen isolates of bacteria and yeasts. Lower
      prevalence organisms may be supplemented from banked culture collections.

      The MBT-CA system uses an organism identification based on unique protein patterns of the
      microorganisms obtained from mass spectrometry. The test organism's spectrum (a pattern of
      mass peaks) is compared with a reference spectra library (database). Using biostatistical
      analysis, a probability ranking of the organism identification is generated. The probability
      ranking is represented as a log(score) between 0.00 and 3.00. Organism identification is
      reported with high confidence if the log(score) is â‰¥ 2.00.  An organism identification is
      reported with low confidence if the log(score) is between 1.70 and &lt;2.00.

      In the last step the samples are sent to a special site for sequencing. Finally, the
      respective sequencing results are compared with the MBT-CA results.

      Target microorganisms of study:

        1. GN Acinetobacter haemolyticus

        2. GN Acinetobacter johnsonii

        3. GN Acinetobacter junii

        4. AA Actinomyces hyovaginalis

        5. AA Actinomyces meyeri

        6. AA Actinomyces neuii

        7. AA Actinomyces odontolyticus

        8. AA Actinomyces oris

        9. GP Aerococcus urinae

       10. GP Aerococcus viridans

       11. GN Aeromonas salmonicida

       12. GP Alloiococcus otitis

       13. AA Anaerococcus murdochii

       14. AA Anaerococcus vaginalis

       15. AA Bacteroides fragilis

       16. AA Bacteroides ovatus

       17. AA Bacteroides thetaiotaomicron

       18. AA Bacteroides uniformis

       19. AA Bacteroides vulgatus

       20. GN Bordetella bronchiseptica

       21. GN Bordetella hinzii

       22. GN Bordetella parapertussis

       23. GN Bordetella pertussis

       24. GN Bordetella petrii

       25. GP Brevibacterium casei

       26. GN Brevundimonas diminuta

       27. MA Campylobacter coli

       28. MA Campylobacter curvus

       29. MA Campylobacter gracilis

       30. MA Campylobacter jejuni

       31. MA Campylobacter ureolyticus

       32. YE Candida albicans

       33. YE Candida boidinii

       34. YE Candida dubliniensis

       35. YE Candida duobushaemulonii

       36. YE Candida glabrata

       37. YE Candida haemulonii

       38. YE Candida inconspicua

       39. YE Candida metapsilosis

       40. YE Candida orthopsilosis

       41. YE Candida parapsilosis

       42. YE Candida pararugosa

       43. YE Candida tropicalis

       44. YE Candida_guilliermondii[ana] (Pichia_guilliermondii[teleo])

       45. YE Candida_guilliermondii_var_membranaefaciens[ana] (Pichia_ohmeri[teleo])

       46. YE Candida_kefyr[ana] (Kluyveromyces_marxianus_ssp_marxianus[teleo])

       47. YE Candida_krusei[ana] (Issatchenkia_orientalis[teleo])

       48. YE Candida_lambica[ana] (Pichia_fermentans[teleo])

       49. YE Candida_lipolytica[ana] (Yarrowia_lipolytica[teleo])

       50. YE Candida_lusitaniae[ana] (Clavispora_lusitaniae[teleo])

       51. YE Candida_norvegensis[ana] (Pichia_norvegensis[teleo])

       52. YE Candida_pelliculosa[ana] (Pichia_anomala[teleo])

       53. YE Candida_robusta[ana] (Saccharomyces_cerevisiae[teleo])

       54. YE Candida_valida[ana] (Pichia_membranifaciens[teleo])

       55. GN Capnocytophaga ochracea

       56. GN Capnocytophaga sputigena

       57. GN Chryseobacterium gleum

       58. GN Chryseobacterium indologenes

       59. AA Clostridium difficile

       60. AA Clostridium perfringens

       61. GP Corynebacterium amycolatum

       62. GP Corynebacterium aurimucosum

       63. GP Corynebacterium bovis

       64. GP Corynebacterium diphtheriae

       65. GP Corynebacterium glucuronolyticum

       66. GP Corynebacterium glutamicum

       67. GP Corynebacterium jeikeium

       68. GP Corynebacterium kroppenstedtii

       69. GP Corynebacterium macginleyi

       70. GP Corynebacterium minutissimum

       71. GP Corynebacterium propinquum

       72. GP Corynebacterium pseudodiphtheriticum

       73. GP Corynebacterium pseudotuberculosis

       74. GP Corynebacterium riegelii

       75. GP Corynebacterium striatum

       76. GP Corynebacterium tuberculostearicum

       77. GP Corynebacterium ulcerans

       78. GP Corynebacterium urealyticum

       79. GP Corynebacterium xerosis

       80. GN Cronobacter sakazakii

       81. YE Cryptococcus neoformans_var_grubii

       82. YE Cryptococcus neoformans_var_neoformans

       83. YE Cryptococcus_gattii[ana] (Filobasidiella_bacillispora[teleo])

       84. GN Cupriavidus pauculus

       85. YE Debaryomyces hansenii

       86. GN Delftia acidovorans

       87. GP Dermacoccus nishinomiyaensis

       88. GN Edwardsiella tarda

       89. GN Elizabethkingia meningoseptica

       90. GN Enterobacter amnigenus

       91. GP Enterococcus avium

       92. GP Enterococcus casseliflavus

       93. GP Enterococcus faecalis

       94. GP Enterococcus faecium

       95. GP Enterococcus gallinarum

       96. GP Enterococcus hirae

       97. AA Finegoldia magna

       98. AA Fusobacterium canifelinum

       99. AA Fusobacterium necrophorum

      100. AA Fusobacterium nucleatum

      101. GP Gardnerella vaginalis

      102. GP Gemella haemolysans

      103. GP Gemella sanguinis

      104. YE Geotrichum_candidum[ana] (Galactomyces_geotrichum[teleo])

      105. YE Geotrichum_capitatum[ana] (Magnusiomyces_capitatus[teleo]#)

      106. GP Granulicatella adiacens

      107. GN Haemophilus haemolyticus

      108. GN Haemophilus parahaemolyticus

      109. GN Kingella kingae

      110. YE Kloeckera_apiculata[ana] (Hanseniaspora_uvarum[teleo])

      111. GP Kocuria kristinae

      112. GP Kytococcus sedentarius

      113. GP Lactococcus garvieae

      114. GP Lactococcus lactis

      115. GP Leuconostoc mesenteroides

      116. GP Macrococcus caseolyticus

      117. GP Micrococcus luteus

      118. GN Moraxella_sg_Moraxella nonliquefaciens

      119. GN Myroides odoratimimus

      120. GN Myroides odoratus

      121. GN Oligella ureolytica

      122. GN Oligella urethralis

      123. AA Parabacteroides distasonis

      124. GP Pediococcus pentosaceus

      125. AA Peptoniphilus harei

      126. AA Peptostreptococcus anaerobius

      127. GN Plesiomonas shigelloides

      128. AA Porphyromonas gingivalis

      129. AA Porphyromonas somerae

      130. AA Prevotella bivia

      131. AA Prevotella buccae

      132. AA Prevotella denticola

      133. AA Prevotella intermedia

      134. AA Prevotella loescheii

      135. AA Prevotella melaninogenica

      136. AA Propionibacterium acnes

      137. GN Pseudomonas oryzihabitans

      138. GN Pseudomonas stutzeri

      139. GN Rhizobium radiobacter

      140. GP Rothia aeria

      141. GP Rothia dentocariosa

      142. GP Rothia mucilaginosa

      143. GN Serratia plymuthica

      144. GN Serratia rubidaea

      145. GP Staphylococcus aureus

      146. GP Staphylococcus auricularis

      147. GP Staphylococcus capitis

      148. GP Staphylococcus caprae

      149. GP Staphylococcus carnosus

      150. GP Staphylococcus cohnii

      151. GP Staphylococcus epidermidis

      152. GP Staphylococcus equorum

      153. GP Staphylococcus felis

      154. GP Staphylococcus haemolyticus

      155. GP Staphylococcus hominis

      156. GP Staphylococcus lugdunensis

      157. GP Staphylococcus lutrae

      158. GP Staphylococcus pasteuri

      159. GP Staphylococcus pettenkoferi

      160. GP Staphylococcus pseudintermedius

      161. GP Staphylococcus saccharolyticus

      162. GP Staphylococcus saprophyticus

      163. GP Staphylococcus schleiferi

      164. GP Staphylococcus simulans

      165. GP Staphylococcus vitulinus

      166. GP Staphylococcus warneri

      167. GP Streptococcus agalactiae

      168. GP Streptococcus anginosus

      169. GP Streptococcus constellatus

      170. GP Streptococcus dysgalactiae

      171. GP Streptococcus gallolyticus

      172. GP Streptococcus gordonii

      173. GP Streptococcus infantis

      174. GP Streptococcus intermedius

      175. GP Streptococcus lutetiensis

      176. GP Streptococcus mitis

      177. GP Streptococcus mutans

      178. GP Streptococcus oralis

      179. GP Streptococcus pneumoniae

      180. GP Streptococcus pyogenes

      181. GP Streptococcus salivarius_ssp_salivarius

      182. GP Streptococcus salivarius_ssp_thermophilus

      183. AA Sutterella wadsworthensis

      184. YE Trichosporon asahii

      185. GN Vibrio parahaemolyticus

      186. GN Vibrio vulnificus

      AA = Anaerobes GN = Gram neg. Aerobes GP = Gram pos. Aerobes MA = Microaerophilics YE =
      Yeasts
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Substantial equivalence of MBT-CA with sequencing concerning determination of the respective bacteria and yeasts</measure>
    <time_frame>half a year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with infections from certain yeasts, Gram positive or certain Gram negative
        bacteria (see Further Information / Target microorganisms of study)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Patients with infections from certain yeasts, Gram positive or Gram negative bacteria
        (see Detailed Description)

        Exclusion Criteria:

        -Patients without infections from the quoted microorganisms (see Detailed Description)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 26, 2014</lastchanged_date>
  <firstreceived_date>March 25, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
